BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11490306)

  • 21. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adriamycin and mitomycin dose-dependently downregulate X-kinked inhibitor of apoptosis protein in human bladder cancer cells].
    Yin ZF; Li M; Lai YQ; Yuan YM; Liu G; Chen L; Gan L; Na YQ
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(25):1774-7. PubMed ID: 17054846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bcl-XL and Bcl-2 expression in bilharzial squamous cell carcinoma of the urinary bladder: which protein is prognostic?
    Hameed DA; Abdel Raheem AM; Mosad E; Hammouda HM; Kamel NA; Abdel Aziz MA
    Urology; 2008 Aug; 72(2):374-8. PubMed ID: 18342927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of bcl-2 and p16 in transitional cell carcinoma of urinary bladder].
    Leng J; Zhang Y; Yao X; Wen K
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):40-3. PubMed ID: 11831985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
    Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS
    Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma.
    Liu H; Schwartz MJ; Hwang DH; Scherr DS
    BJU Int; 2008 Apr; 101(7):894-901. PubMed ID: 18241249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of antisense oligonucleotides in the treatment of bladder cancer.
    Duggan BJ; Gray S; Johnston SR; Williamson K; Miyaki H; Gleave M
    Urol Res; 2002 Jul; 30(3):137-47. PubMed ID: 12111175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of cytotoxic effects induced by bcl-2 and bcl-xL antisense-oligodeoxynucleotides in normal urothelium and transitional cell carcinoma.
    Gabriel U; Bolenz C; Becker A; Schaaf A; Steidler A; Trojan L; Weiss C; Michel MS
    Oncol Rep; 2008 Dec; 20(6):1419-23. PubMed ID: 19020723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Over expression of metallothionein predicts resistance of transitional cell carcinoma of bladder to intravesical mitomycin therapy.
    Lynn NN; Howe MC; Hale RJ; Collins GN; O'Reilly PH
    J Urol; 2003 Feb; 169(2):721-3. PubMed ID: 12544351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549].
    Zhu BR; Cai JM; Tang GS; Li BL; Gao F; Cui JG; Liu HC
    Ai Zheng; 2007 Aug; 26(8):820-7. PubMed ID: 17697540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G3139 antisense oligonucleotide directed against antiapoptotic Bcl-2 enhances doxorubicin cytotoxicity in the FU-SY-1 synovial sarcoma cell line.
    Joyner DE; Albritton KH; Bastar JD; Randall RL
    J Orthop Res; 2006 Mar; 24(3):474-80. PubMed ID: 16450387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of Caspase-3 and Bcl-2 in bladder transitional carcinoma and their significance].
    Shen HW; Yi L; Wang XM; Yao MJ; Deng JW; Fang JZ; Li MN
    Ai Zheng; 2004 Feb; 23(2):181-4. PubMed ID: 14960240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
    Mezzanzanica D; Balladore E; Turatti F; Luison E; Alberti P; Bagnoli M; Figini M; Mazzoni A; Raspagliesi F; Oggionni M; Pilotti S; Canevari S
    Clin Cancer Res; 2004 Aug; 10(15):5202-14. PubMed ID: 15297424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of gene Livin transfection affect on the apoptosis in bladder carcinoma cells].
    Liu XK; Liu HB; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):853-5. PubMed ID: 18756993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.
    Zi X; Simoneau AR
    Cancer Res; 2005 Apr; 65(8):3479-86. PubMed ID: 15833884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
    Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
    Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis of bladder cancer cells induced by short-term and low-dose Mitomycin-C: potential molecular mechanism and clinical implication.
    Liu J; Wang Q; Wang X; Sun Y; Chen XY; Kong Q; Zhang KL; Li H
    Int J Mol Med; 2003 Mar; 11(3):389-94. PubMed ID: 12579346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of Bcl-2 expression in bladder cancer: relation to schistosomiasis.
    Swellam M; Abd-Elmaksoud N; Halim MH; Khatab H; Khiry H
    Clin Biochem; 2004 Sep; 37(9):798-802. PubMed ID: 15329319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caspase involved synergistic cytotoxicity of bcl-2 antisense oligonucleotides and adriamycin on transitional cell cancer cells.
    Bilim V; Kasahara T; Noboru H; Takahashi K; Tomita Y
    Cancer Lett; 2000 Jul; 155(2):191-8. PubMed ID: 10822135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of treatment with antisense oligonucleotides complementary to immunoglobulin sequences of bcl-2/immunoglobulin fusion transcript in a t(14;18) human lymphoma-scid mouse model.
    Smith MR; Xie T; Zhou ZZ; Joshi I
    Clin Cancer Res; 2001 Feb; 7(2):400-6. PubMed ID: 11234896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.